Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02880163
NA

REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam

Sponsor: Arsenal Medical, Inc.

View on ClinicalTrials.gov

Summary

The purpose of this study is to demonstrate safety, effectiveness and benefit-risk profile of ResQFoam for the inhospital treatment of exsanguinating, intraabdominal haemorrhage due to trauma in patients where emergent laparotomy is required.

Official title: Reducing Exsanguination Via In-Vivo Expandable Foam

Key Details

Gender

All

Age Range

15 Years - Any

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2025-08-07

Completion Date

2026-12-31

Last Updated

2025-11-10

Healthy Volunteers

No

Interventions

DEVICE

ResQFoam

Hemostatic device for the treatment of emergent, exsanguinating, Class III or IV intraabdominal hemorrhagic shock in subjects due to trauma

Locations (2)

University of Alabama at Birmingham

Birmingham, Alabama, United States

University of Cincinnati

Cincinnati, Ohio, United States